Morgan Stanley’s Tonix Pharmaceuticals TNXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $681K | Buy |
18,928
+16,251
| +607% | +$585K | ﹤0.01% | 5309 |
|
|
2025
Q1 | $47.9K | Buy |
2,677
+2,494
| +1,363% | +$44.6K | ﹤0.01% | 6282 |
|
|
2024
Q4 | $6.03K | Buy |
183
+181
| +9,050% | +$5.97K | ﹤0.01% | 6957 |
|
|
2024
Q3 | $37 | Sell |
2
-1
| -33% | -$19 | ﹤0.01% | 7671 |
|
|
2024
Q2 | $176 | Buy |
3
+1
| +50% | +$59 | ﹤0.01% | 7307 |
|
|
2024
Q1 | $1.46K | Sell |
2
-3
| -60% | -$2.19K | ﹤0.01% | 7120 |
|
|
2023
Q4 | $6.42K | Buy |
5
+2
| +67% | +$2.57K | ﹤0.01% | 6944 |
|
|
2023
Q3 | $4.95K | Hold |
3
| – | – | ﹤0.01% | 6917 |
|
|
2023
Q2 | $16.5K | Sell |
3
-33
| -92% | -$182K | ﹤0.01% | 6632 |
|
|
2023
Q1 | $421K | Buy |
36
+25
| +227% | +$292K | ﹤0.01% | 5353 |
|
|
2022
Q4 | $83.8K | Sell |
11
-36
| -77% | -$274K | ﹤0.01% | 6064 |
|
|
2022
Q3 | $498K | Buy |
47
+3
| +7% | +$31.8K | ﹤0.01% | 5270 |
|
|
2022
Q2 | $1.4M | Buy |
44
+43
| +4,300% | +$1.37M | ﹤0.01% | 4788 |
|
|
2022
Q1 | $125K | Hold |
1
| – | – | ﹤0.01% | 6180 |
|
|
2021
Q4 | $313K | Buy |
+1
| New | +$313K | ﹤0.01% | 5820 |
|
|
2021
Q3 | – | Hold |
0
| – | -$314K | – | 6123 |
|
|
2021
Q2 | – | Hold |
0
| – | -$361K | – | 5782 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 5335 |
|
|
2020
Q4 | – | Hold |
0
| – | -$1K | – | 7111 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 6672 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6721 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6705 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 6761 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 6756 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 6747 |
|
|
2019
Q1 | – | Hold |
0
| – | -$2K | – | 6705 |
|
|
2018
Q4 | – | Hold |
0
| – | -$1K | – | 6438 |
|
|
2018
Q3 | – | Hold |
0
| – | -$20K | – | 6651 |
|
|
2018
Q2 | – | Hold |
0
| – | -$13K | – | 6153 |
|
|
2018
Q1 | – | Hold |
0
| – | -$15K | – | 6215 |
|
|
2017
Q4 | – | Hold |
0
| – | -$22K | – | 6148 |
|
|
2017
Q3 | – | Hold |
0
| – | -$22K | – | 5999 |
|
|
2017
Q2 | – | Hold |
0
| – | -$98K | – | 6060 |
|
|
2017
Q1 | – | Hold |
0
| – | -$40K | – | 5607 |
|
|
2016
Q4 | – | Hold |
0
| – | -$39K | – | 5814 |
|
|
2016
Q3 | – | Hold |
0
| – | -$125K | – | 5688 |
|
|
2016
Q2 | – | Hold |
0
| – | -$90K | – | 5147 |
|
|
2016
Q1 | – | Hold |
0
| – | -$758K | – | 5365 |
|
|
2015
Q4 | – | Hold |
0
| – | -$2.18M | – | 4252 |
|
|
2015
Q3 | – | Hold |
0
| – | -$2.18M | – | 3430 |
|
|
2015
Q2 | – | Hold |
0
| – | -$1.26M | – | 3545 |
|
|
2015
Q1 | – | Hold |
0
| – | -$294K | – | 3955 |
|
|
2014
Q4 | – | Hold |
0
| – | -$162K | – | 5017 |
|
|
2014
Q3 | – | Hold |
0
| – | -$1.2M | – | 5253 |
|
|
2014
Q2 | – | Hold |
0
| – | -$813K | – | 3915 |
|
|
2014
Q1 | – | Hold |
0
| – | -$412K | – | 4169 |
|
|
2013
Q4 | – | Hold |
0
| – | -$128K | – | 4591 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 5031 |
|